News & Updates

Show Multimedia Only
Probiotics may improve QoL in lung cancer patients

Probiotics may improve QoL in lung cancer patients

08 May 2024 byAudrey Abella

In lung cancer patients undergoing platinum-based doublet chemotherapy, oral compound probiotic supplements may improve their quality of life (QoL) and relieve gastrointestinal (GI) side effects related to their chemo regimen.

Probiotics may improve QoL in lung cancer patients

08 May 2024
Lung cancer screening tied to reduced mortality

Lung cancer screening tied to reduced mortality

07 May 2024
Speeding COVID-19 symptom recovery may not fall within the realm of nirmatrelvir–ritonavir

Speeding COVID-19 symptom recovery may not fall within the realm of nirmatrelvir–ritonavir

30 Apr 2024 byMike Ng

Treating COVID-19 patients who had been vaccinated or did not have risk factors for severe disease with ritonavir-boosted nirmatrelvir (nirmatrelvir–ritonavir) did not expedite the time to symptom alleviation, reported investigators in the EPIC-SR trial.

Speeding COVID-19 symptom recovery may not fall within the realm of nirmatrelvir–ritonavir

30 Apr 2024
Supplement cocktail boosts COVID-19 treatment arsenal

Supplement cocktail boosts COVID-19 treatment arsenal

29 Apr 2024
Subcutaneous atezolizumab favoured over intravenous infusion

Subcutaneous atezolizumab favoured over intravenous infusion

18 Apr 2024 byJairia Dela Cruz

Nonsmall cell lung cancer (NSCLC) patients with high PD-L1 expression appear to show a strong preference for receiving atezolizumab subcutaneously rather than intravenously.

Subcutaneous atezolizumab favoured over intravenous infusion

18 Apr 2024